Key Points

• Cannabis stocks once soared to billion-dollar valuations, but now trade at penny stock levels after the hype faded.
• 40 U.S. states allow medical marijuana, 24 permit recreational use, yet federal barriers still stifle growth.
• Cannabis stocks are surging in premarket trading today — up as much as 20% — on renewed investor hope for rescheduling.
• It sounds nuts, but SoFi is giving new active invest users up to $1k in stock, see for yourself (Sponsor)

It wasn’t that long ago that cannabis stocks promised explosive growth after Canada legalized recreational marijuana in 2018 and U.S. states accelerated reforms. Investors poured billions into the sector, envisioning a booming green economy. 

Today, 40 states allow medical marijuana, while 24 permit recreational use, covering nearly 55% to 60% of Americans. Yet, the hype faded fast. Pot stocks likeCanopy Growth(NASDAQ:CGC),Tilray Brands(NASDAQ:TLRY),Aurora Cannabis(NASDAQ:ACB), andCronos Group(NASDAQ:CRON) once hit multi-billion-dollar valuations — CGC topped $10 billion, TLRY nearly $20 billion. 

Oversupply, regulatory delays, and fierce competition crushed those dreams. Now, they trade as shadows of their former selves, often dipping into or near penny-stock territory: CGC at $1.34 per share; TLRY at $1.15 per share; ACB, $4.86, and CRON, $2.63. 

This morning, though, pre-market trading tells a different story. Cannabis shares are surging on fresh optimism, with CRON up 13%, ACB climbing 14%, and CGC and TLRY rocketing over 20% each. Here’s why marijuana stocks are sparking up.

Trump’s Win Ignited Federal Reform Dreams

President Trump’s 2024 election victory sparked immediate buzz in the cannabis world. Supporters hoped his administration would finally tackle federal barriers, either through full legalization or rescheduling marijuana from Schedule I to Schedule III. Such a shift could unlock massive gains for pot stocks. 

Right now, with pot still illegal federally, cannabis companies are blocked from accessing traditional banking, forcing many operators into cash-only mode. Despite state laws, banks fear penalties under the Bank Secrecy Act, leaving retail outlets such as dispensaries without basic checking accounts. 

They haul in millions of dollars in cash, heightening robbery risks — industry theft is an increasingly common occurrence, often through “crash-and-grab” robberies —  and complicating tax compliance. Rescheduling would ease these woes, letting firms secure loans, credit lines, and insurance. It could also slash tax rates under IRS Section 280E, which denies deductions for “trafficking” businesses. 

For stocks like CGC and TLRY, with global footprints, this means easier expansion into U.S. markets, potentially doubling revenues as interstate commerce opens.

This Is What Lit the Fuse

Last night, Trump amplified the momentum with a Truth Social post sharing a video from The Commonwealth Project, a Massachusetts group pushing medical cannabis for seniors. The nearly three-minute clip dives into cannabis benefits for age-related issues like pain, arthritis, Alzheimer’s symptoms, and cancer side effects. It spotlights the endocannabinoid system — our body’s natural regulator of mood, sleep, and inflammation — and urges doctors to learn about it.

The video calls for full Medicare coverage of CBD, labeling it the “most important senior health initiative of the century.” It notes 20% of those 65 and older already use CBD, outpacing other age groups. AForbes Healthsurvey last year found an astounding 90% of those 77 or older used CBD. Trump’s post, timed amid White House rescheduling talks, feels like a direct nod to reform. It’s clear why marijuana stocks are surging: Investors see this as pro-cannabis signaling from the top, fueling bets on faster policy wins.

This marks Trump’s strongest cannabis nod yet, building on his past support for state rights and recent rescheduling hints. It spotlights medical uses, where demand is strong — U.S. medical sales hit $10 billion in 2024. Stocks with heavy medical exposure stand to gain most. 

Aurora leads here, with 66% of revenue from medical channels, while Tilray and Canopy Growth leach derive around 35% or so, including EU exports (which is primarily medical use) and U.S. CBD. Cronos has a more recreational tilt to its sales.

Loading stock data...

Key Takeaway

Are pot stocks a buy now? It’s tempting at these stock prices, with reform tailwinds building. A Schedule III move could boost multiples 2x to 3x via tax savings and banking. But temper your enthusiasm: Rescheduling needs Drug Enforcement Administration (DEA) finalization, possible court fights, and congressional buy-in — likely months away, not weeks. 

Trump’s team is prioritizing the economy and the border first. His Truth Social post is a nice injection of adrenaline, but volatility for pot stocks will remain high. There is still black-market competition to contend with, too. In Canada, illicit marijuana is often cheaper than the legal stuff because of regulatory costs. 

For long-term believers, consider buying on dips in cannabis stock prices, but keep your allocation limited. Cannabis investors have been down this path before — and been disappointed. This, however, could be the best shot at changing the playing field yet.

Want Up To $1,000? SoFi Is Giving New Active Invest Users up to $1k in Stock

Looking to grow your money but unsure where to begin? SoFi Active Invest is offering a limited-time promotion—open an account, fund it with $50 or more, and you could receive up to $1,000 in complimentary stock for Active Invest accounts.

From $0 commission trading to fractional shares and automated investing, this app is designed to simplify investing for everyone, whether you’re just starting or already experienced. Its easy to sign up and secure your bonus.(sponsor)

DISCLOSURE:

INVESTMENTS ARE NOT FDIC INSURED • ARE NOT BANK GUARANTEED • MAY LOSE VALUE

Brokerage and Active investing products offered through SoFi Securities LLC, member FINRA(www.finra.org)/SIPC(www.sipc.org).

Advisory services are offered by SoFi Wealth LLC, an SEC-registered investment adviser. Information about SoFi Wealth’s advisory operations, services, and fees is set forth in SoFi Wealth’s current Form ADV Part 2 (Brochure), a copy of which is available upon request and at www.adviserinfo.sec.gov.

Probability of Member receiving $1,000 is a probability of 0.026%; If you don’t make a selection in 30 days, you’ll no longer qualify for the promo. Customer must fund their account with a minimum of $50.00 to qualify.Other fees, such as exchange fees, may apply. Please view our fee disclosure to view a full listing of fees.Investing in alternative investments and/or strategies may not be suitable for all investors and involves unique risks, including the risk of loss. An investor should consider their individual circumstances and any investment information, such as a prospectus, prior to investing. Interval Funds are illiquid instruments, the ability to trade on your timeline may be restricted. Brokerage and Active investing products offered through SoFi Securities LLC, Member FINRA(www.finra.org) /SIPC(www.sipc.org).There are limitations with fractional shares to consider before investing. During market hours fractional share orders are transmitted immediately in the order received. There may be system delays from receipt of your order until execution and market conditions may adversely impact execution prices. Outside of market hours orders are received on a not held basis and will be aggregated for each security then executed in the morning trade window of the next business day at market open. Share will be delivered at an average price received for executing the securities through a single batched order. Fractional shares may not be transferred to another firm. Fractional shares will be sold when a transfer or closure request is initiated. Please consider that selling securities is a taxable event.Options involve risks, including substantial risk of loss and the possibility an investor may lose the entire investment Before trading options please review the Characteristics and Risks of Standardized Options [HYPERLINK: https://www.theocc.com/getmedia/a151a9ae-d784-4a15-bdeb-23a029f50b70/riskstoc.pdfInvesting in an Initial Public Offering (IPO) involves substantial risk, including the risk of loss. Further, there are a variety of risk factors to consider when investing in an IPO, including but not limited to, unproven management, significant debt, and lack of operating history. For a comprehensive discussion of these risks please refer to SoFi Securities’ IPO Risk Disclosure Statement [HYPERLINK https://www.sofi.com/iporisk/]. This should not be considered a recommendation to participate in IPOs and investors should carefully read the offering prospectus to determine whether an offering is consistent with their investment objectives, risk tolerance, and financial situation. New offerings generally have high demand and there are a limited number of shares available for distribution to participants. Many customers may not be allocated shares and share allocations may be significantly smaller than the shares requested in the customer’s initial offer (Indication of Interest). For more information on the allocation process please visit IPO Allocation [HYPERLINK https://support.sofi.com/hc/en-us/articles/360058602892-How-does-SoFi-allocate-IPO-shares].